Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin
Details for Australian Patent Application No. 2005249372 (hide)
International Classifications
Event Publications
16 November 2006 PCT application entered the National Phase
PCT publication WO2005/117911 Priority application(s): WO2005/117911
24 April 2008 Amendment Made
The nature of the amendment is: Amend the priority details to read from 60/658,628 06 May 2004 US to 60/568,628 06 May 2004 US 2005333078 New Index AS The nature of the amendment is: Amend the name of the co-inventor to read from Fretheim, Sedsel to Fretheim Thomassen, Sedsel 2006
14 August 2008 Alteration of Name
The name of the applicant has been altered to Cydex Pharmaceuticals, Inc.
19 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005249373-Use of GPCR54 ligands for the treatment of infertility
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser